1.
Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, Van Soolingen D, et al. Multidrug-resistant
and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.
The Lancet. 2010;375(9728):1830-43.
2.
WHO. Guidelines for the programmatic management of drug-resistant tuberculosis-2011
update. Geneva: World Health Organization; 2011.
3.
WHO. Global Tuberculosis Report. Geneva: World Health Organization. 2018.
4.
Shenoi S, Heysell S, Moll A, Friedland G. Multidrug-resistant and extensively drug-resistant
tuberculosis: consequences for the global HIV community. Current opinion in infectious
diseases. 2009;22(1):11.
5.
WHO. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant
tuberculosis: World Health Organization; 2014.
6.
WHO. Treatment of tuberculosis: guidelines 4th Edition. 4th Edition ed: World Health
Organization and Stop TB Initiative; 2010.
7.
WHO. WHO consolidated guidelines on drug-resistant tuberculosis treatment. 2019.
8.
Falzon D, Mirzayev F, Wares F, Baena IG, Zignol M, Linh N, et al. Multidrug-resistant
tuberculosis around the world: what progress has been made? European Respiratory Journal.
2015;45(1):150-60.
9.
Du Cros P, Swaminathan A, Bobokhojaev O, Sharifovna Z, Martin C, Herboczek K, et al.
Challenges and solutions to implementing drug-resistant tuberculosis programmes for
children in Central Asia. Public health action. 2015;5(2):99-102.
10.
Lunte K, Cordier-Lassalle T, Keravec J. Reducing the price of treatment for multidrug-resistant
tuberculosis through the Global Drug Facility. Bulletin of the World Health Organization.
2015;93:279-82.
11.
MOH, ICF. Uganda AIDS indicator survey 2011: UgandaMinistry of Health, ICF International;
2012.
12.
WHO. Global Tuberculosis Report. Geneva: World Health Organization. 2015.
13.
Luyirika E, Nsobya H, Batamwita R, Busingye P, Musoke W, Nabiddo L, et al. A home-based
approach to managing multi-drug resistant tuberculosis in Uganda: a case report. AIDS
research and therapy. 2012;9(1):12.
14.
WHO. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on
surveillance and response. Multidrug and extensively drug-resistant TB (M/XDR-TB):
2010 global report on surveillance and response. 2010.
15.
MOH. National Guidelines for the Programmatic Management of Drug Resistant-TB. Kampala,
Uganda: Uganda Ministry of Health; 2015.
16.
MOH. National Tuberculosis and Leprosy Programme Manual, 2nd edition. Kampala, Uganda:
Uganda Ministry of Health; 2010.
17.
WHO. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral
drugs for treating and preventing HIV infection: recommendations for a public health
approach. 2014.
18.
Laserson KF, Thorpe L, Leimane V, Weyer K, Mitnick C, Riekstina V, et al. Speaking
the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
The International Journal of Tuberculosis and Lung Disease. 2005;9(6):640-5.
19.
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, et al. Multidrug resistant
pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient
data meta-analysis of 9,153 patients. PLoS medicine. 2012;9(8):e1001300.
20.
Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant
tuberculosis: a systematic review and meta-analysis. PloS one. 2009;4(9):e6914.
21.
Lalloo UG, Naidoo R, Ambaram A. Recent advances in the medical and surgical treatment
of multi-drug resistant tuberculosis. Current opinion in pulmonary medicine. 2006;12(3):179-85.
22.
Loveday M, Wallengren K, Voce A, Margot B, Reddy T, Master I, et al. Comparing early
treatment outcomes of MDR-TB in decentralized and centralized settings in KwaZulu-Natal,
South Africa. The international journal of tuberculosis and lung disease. 2012;16(2):209-15.
23.
Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H. Early outcomes of
MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PloS one. 2009;4(9):e7186.
24.
Oladimeji O, Isaakidis P, Obasanya OJ, Eltayeb O, Khogali M, Van den Bergh R, et al.
Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis
patients: results from a nationwide cohort in Nigeria. PloS one. 2014;9(4):e94393.
25.
Mpagama SG, Heysell SK, Ndusilo ND, Kumburu HH, Lekule IA, Kisonga RM, et al. Diagnosis
and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis
patients in Tanzania. PloS one. 2013;8(5):e62034.
26.
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, et
al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerging
infectious diseases. 2006;12(9):1389.
27.
Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, et al. Community-based
therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of
Medicine. 2003;348(2):119-28.
28.
Heller T, Lessells R, Wallrauch C, Bärnighausen T, Cooke G, Mhlongo L, et al. Community-based
treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
The international journal of tuberculosis and lung disease. 2010;14(4):420-6.
29.
Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection
and multidrug-resistant tuberculosis—the perfect storm. The Journal of infectious
diseases. 2007;196(Supplement_1):S86-S107.
30.
Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, et al. Ambulatory
multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients
in a slum setting in Mumbai, India. PloS one. 2011;6(12):e28066.